Clin2
NCT07021430Possibly a fitRecruiting

Preventing Malaria in Pregnancy with Focal Drug Treatment

Malaria Prevention

Treatments studied

Part of Infections clinical trials.

This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
300 people
Ages
Any age
Study type
Interventional

Who can take part

  • You live in Kasese District for at least 6 months of the year and plan to stay for the next 6 months.
  • You are pregnant, at least 18 years old, and less than 22 weeks along.
  • You plan to get prenatal care and give birth at Bugoye Level III Health Center.
  • You do not have HIV.
  • You are willing to take study medication and follow study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07387341Not yet recruiting
Mosquito repellent for malaria prevention in children

This trial tests a long-acting mosquito repellent that could help prevent malaria. It is for children living in the study area, and simply involves letting us know if your child is home for a visit.

Kisumu
NCT06962319Recruiting· Phase 3
Malaria treatment safety in early pregnancy

This trial tests how safe antimalarial drugs are during the first few months of pregnancy. It aims to find treatments that protect both mother and baby.

Nanoro
NCT07389057Recruiting
Malaria prevention study with combined medicines in Ghana

This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.

Accra, Eastern Region
NCT07322068Not yet recruiting· Phase 4
Malaria prevention study for children in Uganda

This study tests a new way to prevent malaria in children living in Busia District, Uganda. It combines malaria vaccines with preventive medicine to see if it offers better protection than current methods.

Busia District
NCT07403643Not yet recruiting· Phase 4
Malaria drug study for children in Papua New Guinea

This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.

Madang, Madang Province
NCT07798583Not yet recruiting· Phase 3
Malaria prevention study for Kenyan schoolchildren

This study tests different schedules of a malaria prevention medicine to see which works best for improving school attendance, learning, and executive function in children aged 6 to 10 in Siaya County, Kenya.

Hear when a new Malaria Prevention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.